Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Free PDFs: Hepatology 2013 (574 pages) – Hepatitis C 2013 Amedeo Smart: the Smartphone Edition	Free Abstracts

Ovarian Neoplasms

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

May 2013
1. YANG L , Li H, Jiang Y, Zuo J, et al
   Inhibition of Mortalin Expression Reverses Cisplatin Resistance and Attenuates Growth of Ovarian Cancer Cells.
   Cancer Lett. 2013 May 9. pii: S0304-3835(13)00372.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2013
2. SEWARD S , Semaan A, Qazi AM, Gruzdyn OV, et al
   EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21 and by inhibiting mutant p53.
   Cancer Lett. 2013 Apr 17. pii: S0304-3835(13)00332.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2013
3. TREECK O , Schuler S, Haring J, Skrzypczak M, et al
   Icb-1 gene counteracts growth of ovarian cancer cell lines.
   Cancer Lett. 2013 Mar 6. pii: S0304-3835(13)00212.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2012
4. NADKARNI NJ , De Geest K, Neff T, De Young B, et al
   Microvessel Density and p53 Mutations in Advanced-Stage Epithelial Ovarian Cancer.
   Cancer Lett. 2012 Dec 22. pii: S0304-3835(12)00733.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2012
5. CHENG JC , Klausen C, Leung PC
   Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells.
   Cancer Lett. 2012 Nov 8. pii: S0304-3835(12)00634.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. FOSTER R , Buckanovich RJ, Rueda BR
   Ovarian Cancer Stem Cells: Working Towards the Root of Stemness.
   Cancer Lett. 2012 Nov 5. pii: S0304-3835(12)00628.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WANG L , Xu Y, Fu L, Li Y, et al
   (5R)-5-hydroxytriptolide (LLDT-8), a novel immunosuppressant in clinical trials, exhibits potent antitumor activity via transcription inhibition.
   Cancer Lett. 2012;324:75-82.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HSUEH SP , Du JL, Hsu WB, Fang CA, et al
   SV40 T/t-common polypeptide enhances the sensitivity of HER2-overexpressing human cancer cells to anticancer drugs cisplatin and doxorubicin.
   Cancer Lett. 2012;324:48-57.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2012
9. CHAO H , Wang L, Hao J, Ni J, et al
   Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway.
   Cancer Lett. 2012 Sep 17. pii: S0304-3835(12)00540.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2012
10. LAU MT , Leung PC
    The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. JIA L , Zhang S, Ye Y, Li X, et al
    Paclitaxel Inhibits Ovarian Tumor Growth by Inducing Epithelial Cancer Cells to Benign Fibroblast-like cells.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2012
12. CASTELLS M , Thibault B, Mery E, Golzio M, et al
    Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. AHN MY , Kang DO, Na YJ, Yoon S, et al
    Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. SHAHZAD MM , Shin YH, Matsuo K, Lu C, et al
    Biological Significance of HORM-A Domain Containing Protein 1 (HORMAD1) in Epithelial Ovarian Carcinoma.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2012
15. MERTENS-WALKER I , Baxter RC, Marsh DJ
    Gonadotropin signalling in epithelial ovarian cancer.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
16. LAU MT , So WK, Leung PC
    Integrin beta1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BURGOS-OJEDA D , Rueda BR, Buckanovich RJ
    Ovarian Cancer Stem Cell Markers: Prognostic and Therapeutic Implications.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
18. YANG X , Wang J, Zhou Y, Wang Y, et al
    Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ABU-YOUSIF AO , Moor AC, Zheng X, Savellano MD, et al
    Epidermal Growth Factor Receptor-Targeted Photosensitizer Selectively Inhibits EGFR Signaling and Induces Targeted Phototoxicity In Ovarian Cancer Cells.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GLOSS BS , Samimi G
    Epigenetic Biomarkers in Epithelial Ovarian Cancer.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
21. SCHAFER H , Dieckmann C, Korniienko O, Moldenhauer G, et al
    Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. GLOSS BS , Patterson KI, Barton CA, Gonzalez M, et al
    Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. SHAH PP , Kakar SS
    Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin.
    Cancer Lett. 2011;311:66-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
24. GEST C , Mirshahi P, Li H, Pritchard LL, et al
    Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ZHOU S , Li Y, Huang F, Zhang B, et al
    Live-attenuated measles virus vaccine confers cell contact loss and apoptosis of ovarian cancer cells via ROS-induced silencing of E-cadherin by methylation.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
26. LEE KB , Byun HJ, Park SH, Park CY, et al
    CYR61 controls p53 and NF-kappaB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
27. CHEN X , Yan Q, Li S, Zhou L, et al
    Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. THERIAULT BL , Nachtigal MW
    Human ovarian cancer cell morphology, motility, and proliferation are differentially influenced by autocrine TGFbeta superfamily signalling.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
29. MANDAI M , Matsumura N, Baba T, Yamaguchi K, et al
    Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
30. SUN H , Yu T, Li J
    Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: More than just AKT inhibition.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. TAN D , Chen KE, Khoo T, Walker AM, et al
    Prolactin increases survival and migration of ovarian cancer cells: Importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. CHUANG TC , Hsu SC, Cheng YT, Shao WS, et al
    Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SOLAR P , Sytkowski AJ
    Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. COHEN M , Petignat P
    Purified autoantibodies against glucose-regulated protein 78 (GRP78) promote apoptosis and decrease invasiveness of ovarian cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
35. CHOI YP , Shim HS, Gao MQ, Kang S, et al
    Molecular portraits of intratumoral heterogeneity in human ovarian cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
36. SU W , Huang L, Ao Q, Zhang Q, et al
    Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1alpha
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
37. SUZUKI M , Iwasaki M, Sugio A, Hishiya A, et al
    BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through a media sponsorship by Boehringer Ingelheim.

All AMEDEO services are free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Amedeo is a Flying Publisher website.    Design: